- Home
- STKS vs BYSI Comparison
STKS vs BYSI Comparison
Compare STKS & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STKS | BYSI |
|---|---|---|
| Founded | 2004 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.3M | 79.0M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | STKS | BYSI |
|---|---|---|
| Price | $2.26 | $1.53 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $4.38 | N/A |
| AVG Volume (30 Days) | 42.3K | ★ 54.7K |
| Earning Date | 03-09-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $820,588,000.00 | N/A |
| Revenue This Year | $25.55 | N/A |
| Revenue Next Year | $6.27 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 51.57 | N/A |
| 52 Week Low | $1.70 | $0.98 |
| 52 Week High | $5.26 | $3.44 |
Technical Indicators
Market Signals| Indicator | STKS | BYSI |
|---|---|---|
| Relative Strength Index (RSI) | 54.57 | 41.32 |
| Support Level | $2.26 | $1.51 |
| Resistance Level | $2.41 | $1.77 |
| Average True Range (ATR) | 0.16 | 0.12 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 42.47 | 53.85 |
Price Performance
Historical ComparisonAbout STKS The ONE Group Hospitality Inc.
The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through four segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.